Pacira BioSciences Rebuts DOMA Perpetual’s Claims on Intellectual Property and Affirms Robust Patent Strategy
Company details strengthened patent portfolio and ongoing litigation efforts to protect EXPAREL franchise amid recent Paragraph IV challenges
Pacira BioSciences has issued a comprehensive statement addressing inaccuracies in DOMA Perpetual Capital Management’s recent assertions regarding the company’s intellectual property approach. Emphasizing its strong patent estate and ongoing legal actions, Pacira highlights key developments including patent reexaminat…